Suzhou, China · Founded 2020 · Privately Held (backing)
Developer of biosynthesis designed to provide overall solutions for molecular diagnosis, nucleic acid chemistry, synthetic biology and antibody drug development. Junji Bio is based in Suzhou, China and was founded in 2020. It has raised $14.1 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.1M
Last round
—
Team — not yet on record
No current team members for Junji Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Junji Bio with a free account
·Watch Junji Bio: the Monday email on marks, rounds and moves
